Dong Gao1, Xianying Ma2. 1. Department of Dermatology, Yantai Yuhuangding Hospital, Yantai, China - gaodongyantai@163.com. 2. Department of Dermatology, Yantai Yuhuangding Hospital, Yantai, China.
Abstract
INTRODUCTION: Recently, different studies suggested that the elevated serum concentration of lactate dehydrogenase (LDH) was associated with poor prognosis of melanoma. However, the results were controversial. BACKGROUND: We decided to perform a meta-analysis to assess the association between serum concentration of LDH and the overall survival (OS) of melanoma. EVIDENCE ACQUISITION: Online electronic databases (PubMed, EMBASE, and Cochrane database) were searched. The association of LDH and the OS of melanoma was estimated by hazard ratio (HR) with its 95% confidence interval (CI). EVIDENCE SYNTHESIS: A total of 13 eligible studies with 4036 patients met the inclusion criteria. LDH level was significantly associated with OS in melanoma patients (HR=1.97, 95% CI 1.62-2.40, P<0.00001; I2=78%). In addition, LDH level was also significantly associated with OS in stage IV melanoma patients (HR=1.99, 95% CI 1.59-2.50, P<0.00001; I2=79%). In the subgroup analysis by study design, a statistically significant association was found in retrospective cohort studies (HR=2.31, 95% CI 1.18- 4.51, P=0.01; I2=87%) and in prospective cohort studies (HR=1.87, 95% CI 1.55-2.26, P<0.00001; I2=73%). In the subgroup analysis by sample size, LDH level was significantly associated with OS in large sample size studies (HR=1.61, 95% CI 1.17-2.23, P=0.003; I2=73%) and small sample size studies (HR=2.18, 95% CI 1.69-2.80, P <0.00001; I2=79%). CONCLUSIONS: In conclusion, this meta-analysis suggested that high LDH level might be a predictor of poor prognosis of melanoma patients.
INTRODUCTION: Recently, different studies suggested that the elevated serum concentration of lactate dehydrogenase (LDH) was associated with poor prognosis of melanoma. However, the results were controversial. BACKGROUND: We decided to perform a meta-analysis to assess the association between serum concentration of LDH and the overall survival (OS) of melanoma. EVIDENCE ACQUISITION: Online electronic databases (PubMed, EMBASE, and Cochrane database) were searched. The association of LDH and the OS of melanoma was estimated by hazard ratio (HR) with its 95% confidence interval (CI). EVIDENCE SYNTHESIS: A total of 13 eligible studies with 4036 patients met the inclusion criteria. LDH level was significantly associated with OS in melanomapatients (HR=1.97, 95% CI 1.62-2.40, P<0.00001; I2=78%). In addition, LDH level was also significantly associated with OS in stage IV melanomapatients (HR=1.99, 95% CI 1.59-2.50, P<0.00001; I2=79%). In the subgroup analysis by study design, a statistically significant association was found in retrospective cohort studies (HR=2.31, 95% CI 1.18- 4.51, P=0.01; I2=87%) and in prospective cohort studies (HR=1.87, 95% CI 1.55-2.26, P<0.00001; I2=73%). In the subgroup analysis by sample size, LDH level was significantly associated with OS in large sample size studies (HR=1.61, 95% CI 1.17-2.23, P=0.003; I2=73%) and small sample size studies (HR=2.18, 95% CI 1.69-2.80, P <0.00001; I2=79%). CONCLUSIONS: In conclusion, this meta-analysis suggested that high LDH level might be a predictor of poor prognosis of melanomapatients.
Authors: Seyed Pairawan; Kenneth R Hess; Filip Janku; Nora S Sanchez; Kenna R Mills Shaw; Cathy Eng; Senthilkumar Damodaran; Milind Javle; Ahmed O Kaseb; David S Hong; Vivek Subbiah; Siqing Fu; David R Fogelman; Victoria M Raymond; Richard B Lanman; Funda Meric-Bernstam Journal: Clin Cancer Res Date: 2019-12-18 Impact factor: 12.531
Authors: Sherise D Ferguson; Shivani Bindal; Roland L Bassett; Lauren E Haydu; Ian E McCutcheon; Amy B Heimberger; Jing Li; Barbara J O'Brien; Nandita Guha-Thakurta; Michael T Tetzlaff; Hussein Tawbi; Michael A Davies; Isabella C Glitza Journal: J Neurooncol Date: 2019-03-07 Impact factor: 4.130
Authors: Emanuelle M Rizk; Angelina M Seffens; Megan H Trager; Michael R Moore; Larisa J Geskin; Robyn D Gartrell-Corrado; Winston Wong; Yvonne M Saenger Journal: Am J Clin Dermatol Date: 2020-02 Impact factor: 7.403
Authors: Christoph Minichsdorfer; Andreas Gleiss; Marie-Bernadette Aretin; Manuela Schmidinger; Thorsten Fuereder Journal: Ann Med Date: 2022-12 Impact factor: 5.348